Getting Coffee-Bombed

This week, I’ve been getting coffee-bombed. And am I happy about that? You bet!
You see, my favorite coffee of all time is found in Roanoke, VA – Mill Mountain Blend. They roast it right there on the premises in downtown Roanoke, and aroma is out of this world. It’s STRONG coffee, the way I like [...]

Read Full Post »

After Hours

Awesome view of the Eiffel Tower at sunset.
Awkward family photos. Pretty funny stuff here!
Aerial virtual tour of NYC. Very, very cool.
10 most fascinating natural phenomena (with eye-grabbing photos).
Infinite photograph. Just keep clicking and diving deeper. Wow.
————-

Connect with Steve Woodruff

Read Full Post »

Getting Started with Social Networking

It can be a little bit intimidating for many folks, getting started with social networking. What’s a blog? How can I use LinkedIn? Should I be on Facebook? Does Twitter matter? How do I start?
Every active networker had to just…start…at some point. Maybe we can make things a little easier.
Here is a free e-book(let) download [...]

Read Full Post »

SPBT 2009 – A Wrap-up

I got back last evening from the annual Society of Pharmaceutical and Biotech Trainers conference, held this year in Chicago’s Hyatt Regency (downtown). I think this was my 12th or 13th year at the event.
I’m tired! Happily so, however – I cannot remember ever enjoying a more terrific time of non-stop networking.
Attendance was down this [...]

Read Full Post »

Today’s Top (8) in Pharma 050709

This will probably be the last Top Three post for about a week or so, as I head out to Chicago for the SPBT (Society of Pharmaceutical and Biotech Trainers) conference. And there’s a bit of backlog today, so here goes – more than three!
Acorda shares jump after its experimental MS pill gets a priority [...]

Read Full Post »

Heading to Chicago for SPBT?

The annual Society of Pharmaceutical and Biotech Trainers conference is almost upon us! It can seem a bit overwhelming – loads of sessions, exhibits, and people! I think this is my 13th time attending the event, and the best part is always getting to know (or getting re-acquainted) with so many fine folks.
Networking is going [...]

Read Full Post »

Today’s Top Three in Pharma Cinco de Mayo

Abbott and J&J to duke it out in court over a patent dispute on new rheumatoid arthritis drug.
Amylin eliminating 200 sales positions – Drugmaker Amylin Pharmaceuticals Inc. said Monday it will eliminate about 200 jobs, or more than a third of its sales force, as it combines its primary care and specialty drug sales units.Amylin [...]

Read Full Post »

Today’s Top Three in Pharma 050409

Is Schering’s contraceptive NuvaRing dangerous.? This article raises the question. My take – it’s always a yellow light for me when I see a journalistic heart-string approach based on an isolated (and unproven) incident. What sells newspapers is not the same as science.
Does this really need to be treated as a “new drug”? I have [...]

Read Full Post »

Today’s Top Three in Pharma 050109

FDA Approval: Novartis‘ Exforge HCT combo high-blood pressure pill.
FDA Approval: Medicis‘ Dysport, a Botox competitor. And both end up with black box warnings!
PDI and Novartis end a co-promote agreement.
Pre-merger trading over at Schering? Hmmm…
——
Subscribe to the Impactiviti blog via e-mail
Subscribe to the Impactiviti blog via RSS
Connect with Steve Woodruff

Read Full Post »